Crizotinib in Patients With MET-Amplified NSCLC
D. Ross Camidge, Gregory A. Otterson, Jeffrey W. Clark, Sai‐Hong Ignatius Ou, Jared Weiss, Steven Ades, Geoffrey I. Shapiro, Mark A. Socinski, Danielle Murphy, Umberto Conte, Yiyun Tang, Sherry Wang, Keith D. Wilner, Liza C. Villaruz
Topics & Concepts
CrizotinibMedicineFluorescence in situ hybridizationInternal medicineROS1Retrospective cohort studyGene duplicationGastroenterologyProgression-free survivalHazard ratioOncologyConfidence intervalOverall survivalAdenocarcinomaLung cancerGeneCancerGeneticsMalignant pleural effusionChromosomeBiologyLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research Studies